Caris Life Sciences Inc
(CAI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 12-2024 | 09-2024 | 06-2024 | |
| Sales | 216,833 | 181,398 | 0 | 101,620 | 100,049 |
| Cost of Goods | 69,327 | 67,713 | N/A | 57,208 | 62,495 |
| Gross Profit | 147,506 | 113,685 | N/A | 44,412 | 37,554 |
| Operating Expenses | 115,191 | 132,387 | 0 | 105,462 | 105,060 |
| Operating Income | 32,642 | -17,989 | N/A | -60,842 | -67,011 |
| Interest Expense | 13,507 | 19,208 | 0 | 13,799 | 13,674 |
| Other Income | 5,190 | -34,593 | 0 | 6,912 | 14,499 |
| Pre-tax Income | 24,325 | -71,790 | 0 | -67,729 | -66,186 |
| Net Income Continuous | 24,325 | -71,790 | N/A | -67,729 | -66,186 |
| Net Income | $24,325 | $-71,790 | $N/A | $-67,729 | $-66,186 |
| EPS Basic Total Ops | 0.09 | -7.97 | N/A | -2.59 | -2.54 |
| EPS Basic Continuous Ops | 0.09 | -1.11 | N/A | -1.90 | -1.87 |
| EPS Diluted Total Ops | 0.08 | -7.97 | N/A | -2.59 | -2.54 |
| EPS Diluted Continuous Ops | 0.08 | -1.11 | N/A | -1.90 | -1.87 |
| EPS Diluted Before Non-Recurring Items | 0.08 | -0.54 | N/A | N/A | N/A |
| EBITDA(a) | $39,975 | $-17,989 | $N/A | $-48,484 | $-67,011 |